UCB

Related Companies

• Vetter Pharma International
• Quotient Sciences
• Asynt
• Romaco Holding GmbH
• ProtaGene
• Symbiosis Pharmaceutical
• Starlab
• Lonza
• Titan Enterprises
• Piramal Pharma Solutions
• PCI Pharma Services
• Biotech Fluidics AB
• Watson Marlow Fluid Technology Solutions
• PSL Powder Systems
• Hoyles Electronic Developments
• Qualicaps
• Asymchem
• Actylis – The Partner of Choice
• SGS Health Sciences
• Marchesini Group

Related Content

Therapeutic: rozanolixizumab for generalised myasthenia gravis

Therapeutic: zilucoplan for myasthenia gravis

Therapeutics: rozanolixizumab for primary immune thrombocytopenia

Therapeutics: dapirolizumab for systemic lupus erythematosus

UCB Pharma chooses South Korean CDMO for the third time

Continuous manufacturing: making it real

Pharmapack Europe 2019 reveals winners

Increasing competition in the psoriasis market

MRC forges two new deals with industry to speed drug discovery

UCB receives EMA approval for pre-filled pen using Bespak Technology

Heptares joins consortium applying cryo-electron microscopy to structure-based drug discovery

Latest EU drug approvals span range of health issues

UCB and Baylor College of Medicine enter neurodegeneration alliance

Steve Turley joins UCB as Managing Director for UK and Ireland

Leukaemia – inotuzumab ozogamicin